Acute kidney injury screening: Difference between revisions
Usama Talib (talk | contribs) Created page with "__NOTOC__ {{Acute kidney injury}} {{CMG}}; {{AE}} ==Overview== There is insufficient evidence to recommend routine screening for [disease/malignancy]. OR According to the..." |
Farima Kahe (talk | contribs) |
||
Line 15: | Line 15: | ||
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3]. | ||
==Screening== | ==Screening== | ||
Several laboratory tests are useful for screening of acute kidney injury among patients with risk factors as following: | |||
*BUN | |||
*Creatinine | |||
*Urine analysis | |||
Electronic health record-based predictive models for acute kidney injury screening among pediatric inpatients, children aged 28 days through 21 years, with sufficient serum creatinine measurements are assessed by followings:<ref name="MalhotraKashani2017">{{cite journal|last1=Malhotra|first1=Rakesh|last2=Kashani|first2=Kianoush B.|last3=Macedo|first3=Etienne|last4=Kim|first4=Jihoon|last5=Bouchard|first5=Josee|last6=Wynn|first6=Susan|last7=Li|first7=Guangxi|last8=Ohno-Machado|first8=Lucila|last9=Mehta|first9=Ravindra|title=A risk prediction score for acute kidney injury in the intensive care unit|journal=Nephrology Dialysis Transplantation|volume=32|issue=5|year=2017|pages=814–822|issn=0931-0509|doi=10.1093/ndt/gfx026}}</ref><ref name="pmid18922990">{{cite journal |vauthors=Wu I, Parikh CR |title=Screening for kidney diseases: older measures versus novel biomarkers |journal=Clin J Am Soc Nephrol |volume=3 |issue=6 |pages=1895–901 |date=November 2008 |pmid=18922990 |doi=10.2215/CJN.02030408 |url=}}</ref> | |||
*Age | |||
*Medication exposures | |||
*Platelet count | |||
*Red blood cell distribution width | |||
* | *Serum phosphorus | ||
* | *Serum transaminases | ||
* | *Hypotension (in ICU patients only) | ||
*PH (in ICU patients only) | |||
==References== | ==References== |
Revision as of 14:21, 29 June 2018
Acute kidney injury Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Acute kidney injury screening On the Web |
American Roentgen Ray Society Images of Acute kidney injury screening |
Risk calculators and risk factors for Acute kidney injury screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
Several laboratory tests are useful for screening of acute kidney injury among patients with risk factors as following:
- BUN
- Creatinine
- Urine analysis
Electronic health record-based predictive models for acute kidney injury screening among pediatric inpatients, children aged 28 days through 21 years, with sufficient serum creatinine measurements are assessed by followings:[1][2]
- Age
- Medication exposures
- Platelet count
- Red blood cell distribution width
- Serum phosphorus
- Serum transaminases
- Hypotension (in ICU patients only)
- PH (in ICU patients only)
References
- ↑ Malhotra, Rakesh; Kashani, Kianoush B.; Macedo, Etienne; Kim, Jihoon; Bouchard, Josee; Wynn, Susan; Li, Guangxi; Ohno-Machado, Lucila; Mehta, Ravindra (2017). "A risk prediction score for acute kidney injury in the intensive care unit". Nephrology Dialysis Transplantation. 32 (5): 814–822. doi:10.1093/ndt/gfx026. ISSN 0931-0509.
- ↑ Wu I, Parikh CR (November 2008). "Screening for kidney diseases: older measures versus novel biomarkers". Clin J Am Soc Nephrol. 3 (6): 1895–901. doi:10.2215/CJN.02030408. PMID 18922990.